Tenet Healthcare (NYSE:THC) Updates FY 2026 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 20.300-21.690 for the period, compared to the consensus EPS estimate of 17.810. The company issued revenue guidance of $21.9 billion-$22.5 billion, compared to the consensus revenue estimate of $22.0 billion.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Royal Bank Of Canada decreased their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Robert W. Baird reduced their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Wells Fargo & Company lifted their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Weiss Ratings cut shares of Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 2nd. Finally, Stephens decreased their price objective on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Seventeen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.47.

Tenet Healthcare Stock Up 22.7%

THC traded up $45.27 during midday trading on Friday, reaching $244.28. The company’s stock had a trading volume of 833,784 shares, compared to its average volume of 1,241,855. Tenet Healthcare has a 1 year low of $146.60 and a 1 year high of $247.21. The stock’s 50-day moving average is $184.43 and its 200-day moving average is $197.37. The firm has a market capitalization of $21.04 billion, a price-to-earnings ratio of 12.71, a PEG ratio of 1.62 and a beta of 1.27. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. The firm had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare will post 17.5 EPS for the current year.

Insider Transactions at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. This represents a 10.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.97% of the company’s stock.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported Q2 2026 earnings of $6.12 per share, well above expectations, and revenue of $5.63 billion, also ahead of Wall Street estimates. Management said stronger same-store revenue growth and expense control drove the beat. Article title
• Positive Sentiment: The company raised FY 2026 guidance, now calling for EPS of $20.30 to $21.69 versus prior expectations around $17.81, while revenue outlook of $21.9 billion to $22.5 billion remains broadly in line with consensus. Article title
• Positive Sentiment: Investors were already positioning for the report as the stock benefited from an improving credit profile, including Moody’s June upgrade, which signaled continued deleveraging and better financial flexibility. Article title
• Neutral Sentiment: Analysts have been generally constructive, with recent price targets and a consensus “Moderate Buy” stance providing additional support, but this is more of a backdrop than a fresh catalyst. Article title
• Negative Sentiment: Insider and congressional trading trends show more selling than buying over the past several months, which could temper enthusiasm, although this does not appear to be driving the stock’s move today. Article title

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of THC. Triumph Capital Management purchased a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare in the second quarter worth approximately $35,000. Meeder Asset Management Inc. grew its position in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after acquiring an additional 114 shares during the period. Geneos Wealth Management Inc. lifted its position in Tenet Healthcare by 50.9% during the second quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock valued at $46,000 after purchasing an additional 89 shares in the last quarter. Finally, Wilkerson Advisory Group LLC purchased a new stake in Tenet Healthcare in the fourth quarter worth about $62,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.